ARTICLE | Clinical News
Emricasan regulatory update
December 9, 2013 8:00 AM UTC
Conatus said FDA granted Orphan Drug designation to emricasan to delay the progression to cirrhosis and end-stage liver disease in liver transplant recipients with reestablished fibrosis. The pan-casp...